Parkinson’s UK has announced £1.83 million in funding for nine new research projects.
The funding will aim to advance our understanding of Parkinson’s and explore new drugs for the future.
The UK charity funds research projects that are based on the priorities of people with Parkinson’s.
It works with a team of scientific experts, alongside people with lived experience of Parkinson’s, to make sure that the research will have the most impact for the Parkinson’s community today and in the future.
Professor David Dexter, Director of Research at Parkinson’s UK, said:
“I’m delighted that Parkinson’s UK has been able to support these pioneering research projects in our latest round of funding.
“Thanks to the generous donations from our supporters, we’ve been able to fund an extra three projects compared to this time last year.”
Parkinson’s UK funds research that can broadly fit into two categories, Cure and Life.
Cure projects aim to find new ways to slow, stop and understand the causes and progression of Parkinson’s.
Life projects work to find ways of treating and managing specific symptoms that can be associated with the disease.
All of the projects in the latest round of funding fit into the Cure category.
The newly-funded projects include a study exploring the impact physical activity on Parkinson’s progression, research investigating genes potentially involved in the disease and the testing of a new drug that could protect supporting cells in the brain.
Prof Dexter added:
“These grants highlight the depth and breadth of the excellent research being carried out by Parkinson’s researchers, and we wish all the applicants every success with their research.”
The charity also has another grant scheme for funding to projects that focus on non-drug treatments and therapies for symptoms of Parkinson’s.
It is currently reviewing new applications, with more details available towards the end of the year.
